DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 157 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $186,526,268 | +14.1% | 12,628,725 | -0.2% | 0.50% | +22.4% |
Q2 2023 | $163,507,290 | +31.7% | 12,655,363 | 0.0% | 0.41% | +30.1% |
Q1 2023 | $124,149,111 | -7.7% | 12,655,363 | +0.1% | 0.31% | -16.1% |
Q4 2022 | $134,493,462 | +2.1% | 12,640,363 | +0.2% | 0.37% | -3.6% |
Q3 2022 | $131,704,000 | -34.7% | 12,615,363 | -21.3% | 0.39% | -29.7% |
Q2 2022 | $201,726,000 | +12.5% | 16,022,731 | -3.1% | 0.55% | +35.6% |
Q1 2022 | $179,270,000 | -21.4% | 16,537,838 | +2.0% | 0.40% | -4.5% |
Q4 2021 | $228,044,000 | -22.6% | 16,207,838 | +5.7% | 0.42% | -24.4% |
Q3 2021 | $294,555,000 | +109.9% | 15,333,400 | +7.6% | 0.56% | +114.9% |
Q2 2021 | $140,301,000 | +13.2% | 14,243,800 | +13.0% | 0.26% | +8.8% |
Q1 2021 | $123,904,000 | +133.1% | 12,604,723 | +5.5% | 0.24% | +120.2% |
Q4 2020 | $53,163,000 | +12.4% | 11,946,800 | +9.1% | 0.11% | -1.8% |
Q3 2020 | $47,290,000 | -52.3% | 10,946,800 | -2.0% | 0.11% | -54.7% |
Q2 2020 | $99,050,000 | +187.3% | 11,166,800 | +14.3% | 0.24% | +142.6% |
Q1 2020 | $34,477,000 | -34.8% | 9,766,800 | +5.6% | 0.10% | -14.4% |
Q4 2019 | $52,892,000 | +69.1% | 9,246,800 | +5.7% | 0.12% | +53.2% |
Q3 2019 | $31,286,000 | +62.0% | 8,751,450 | +80.8% | 0.08% | +63.8% |
Q2 2019 | $19,314,000 | -30.7% | 4,840,700 | +26.9% | 0.05% | -31.9% |
Q1 2019 | $27,876,000 | -16.8% | 3,813,400 | +4.1% | 0.07% | -24.2% |
Q4 2018 | $33,504,000 | +68.9% | 3,661,600 | +129.0% | 0.09% | +97.8% |
Q3 2018 | $19,831,000 | -21.6% | 1,599,252 | -3.5% | 0.05% | -37.8% |
Q2 2018 | $25,281,000 | -47.4% | 1,657,775 | -31.6% | 0.07% | -47.1% |
Q1 2018 | $48,085,000 | +4.3% | 2,422,429 | -1.8% | 0.14% | +7.7% |
Q4 2017 | $46,122,000 | -16.5% | 2,466,468 | -3.9% | 0.13% | -17.7% |
Q3 2017 | $55,207,000 | +64.0% | 2,567,760 | -26.4% | 0.16% | +62.9% |
Q2 2017 | $33,658,000 | +51.1% | 3,487,872 | -6.8% | 0.10% | +51.6% |
Q1 2017 | $22,271,000 | +55.8% | 3,743,151 | +3.4% | 0.06% | +48.8% |
Q4 2016 | $14,296,000 | -54.0% | 3,619,173 | +22.3% | 0.04% | -51.7% |
Q3 2016 | $31,048,000 | -28.1% | 2,959,800 | 0.0% | 0.09% | -29.4% |
Q2 2016 | $43,154,000 | -30.0% | 2,959,800 | -7.7% | 0.13% | -34.0% |
Q1 2016 | $61,670,000 | -14.3% | 3,205,300 | +7.6% | 0.19% | -16.2% |
Q4 2015 | $71,940,000 | -1.5% | 2,977,629 | +0.1% | 0.23% | -3.4% |
Q3 2015 | $73,034,000 | +8.5% | 2,976,119 | +3.6% | 0.24% | +16.8% |
Q2 2015 | $67,315,000 | -8.1% | 2,873,659 | -12.0% | 0.20% | -9.4% |
Q1 2015 | $73,247,000 | +27.3% | 3,265,600 | -4.3% | 0.22% | +25.3% |
Q4 2014 | $57,518,000 | – | 3,411,500 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |